Treatment(s) now being considered-Surgical removal of the tumor Posts on Medivizor
Navigation Menu

Treatment(s) now being considered-Surgical removal of the tumor Posts on Medivizor

Evaluating the long-term outcomes of stereotactic ablative radiation therapy and video-assisted thoracic surgery in patients with early-stage non-small cell lung cancer.

Evaluating the long-term outcomes of stereotactic ablative radiation therapy and video-assisted thoracic surgery in patients with early-stage non-small cell lung cancer.

Posted by on Oct 24, 2021 in Lung cancer | 0 comments

In a nutshell This study evaluated the long-term outcomes of stereotactic ablative radiation therapy (SABR) and video-assisted thoracic surgery (VATS) for the treatment of patients with early-stage non-small cell lung cancer (NSCLC). The data showed that both SABR and VATS led to similar long-term survival outcomes. Some background...

Read More

Evaluating the benefits of radiotherapy after surgery in patients with resectable stage III-N2 non-small cell lung cancer.

Evaluating the benefits of radiotherapy after surgery in patients with resectable stage III-N2 non-small cell lung cancer.

Posted by on Oct 16, 2021 in Lung cancer | 0 comments

In a nutshell This study evaluated the benefits of postoperative radiotherapy (PORT; radiation after surgery) in patients with resectable stage III-N2 non-small-cell lung cancer (NSCLC). The data showed that PORT significantly increased survival without disease progression and reduced the risk of cancer relapse for these patients. Some background...

Read More

Evaluating the best timing of surgery after chemoradiotherapy in patients with locally advanced non-small cell lung cancer.

Evaluating the best timing of surgery after chemoradiotherapy in patients with locally advanced non-small cell lung cancer.

Posted by on Sep 12, 2021 in Lung cancer | 0 comments

In a nutshell This study investigated the optimal time interval between chemoradiotherapy (CRT) and surgery and its impact on survival outcomes in patients with locally advanced (LA) non-small-cell lung cancer (NSCLC). The data showed that surgery within 7 weeks after CRT was associated with improved survival outcomes in these patients. Some...

Read More

Comparing the outcomes of robot-assisted versus video-assisted thoracic surgery for patients with non-small cell lung cancer.

Comparing the outcomes of robot-assisted versus video-assisted thoracic surgery for patients with non-small cell lung cancer.

Posted by on Jun 30, 2021 in Lung cancer | 0 comments

In a nutshell This study compared the short-term and long-term effectiveness between video-assisted thoracic surgery (VATS) and robot-assisted thoracic surgery (RATS) for the treatment of patients with non-small cell lung cancer (NSCLC). The data showed that RATS is a good and safe technique compared with VATS in terms of short-term and long-term...

Read More

Evaluating osimertinib for EGFR positive non-small-cell lung cancer that was surgically removed.

Evaluating osimertinib for EGFR positive non-small-cell lung cancer that was surgically removed.

Posted by on Oct 30, 2020 in Lung cancer | 0 comments

In a nutshell This trial was carried out to assess the effectiveness and safety of osimertinib (Tagrisso) after surgery for EGFR-positive advanced non-small cell lung cancer (NSCLC). The trial found that this treatment improved the outcomes of patients with stage IB to IIIA EGFR-positive NSCLC that was surgically removed. Some...

Read More

Longer survival without progression in patients with NSCLC with nivolumab plus chemotherapy before surgery

Longer survival without progression in patients with NSCLC with nivolumab plus chemotherapy before surgery

Posted by on Oct 25, 2020 in Lung cancer | 0 comments

In a nutshell This study investigated the antitumor activity, safety, and survival after nivolumab (Opdivo) and chemotherapy before surgery for patients with stage IIIA non-small-cell lung cancer (NSCLC). The study showed a high rate of survival without cancer worsening among these patients. Some background NSCLC amounts to over 80% of...

Read More

Searching for patients with non-small cell lung cancer suitable for surgery to test durvalumab with chemotherapy

Posted by on May 19, 2019 in Lung cancer | 0 comments

In a nutshell This phase 3 trial is examining the effectiveness of durvalumab (Imfinzi) combined with chemotherapy vs chemotherapy alone for stage II and III non-small cell lung cancer (NSCLC) before surgery. The main outcome to be measured will be the major pathological response (mPR; 10 percent or fewer alive cancer cells...

Read More

Does the frequency of surveillance after surgery impact survival in patients with NSCLC?

Posted by on Sep 2, 2018 in Lung cancer | 0 comments

In a nutshell This study looked at the frequency of follow-ups after surgical treatment in patients with non-small-cell lung cancer and whether it had an effect on survival. The study concluded that more frequent surveillance was not linked to improved survival.  Some background Surveillance during the post-treatment stage of cancer is a critical...

Read More

Does lymph node removal increase survival in stage 1 non-small-cell lung cancer?

Posted by on Dec 16, 2017 in Lung cancer | 0 comments

In a nutshell This trial looked at the impact of complete lymph node dissection for patients with early stage non-small-cell lung cancer. They concluded that complete dissection of the mediastinal lymph nodes was associated with better survival rates compared to only removing a few lymph nodes for sampling. Some background Surgery to remove tumors...

Read More

What factors are associated with better outcomes in patients with lung cancer treated with radiotherapy?

Posted by on Jul 18, 2015 in Lung cancer | 0 comments

In a nutshell The authors evaluated the factors associated with improved outcomes in patients with lung cancer treated with stereotactic body radiotherapy (SBRT). Some background Stereotactic body radiotherapy (SBRT) is a type of radiotherapy used to treat lung cancer.  With SBRT, a beam of radiation is focused directly on the tumor,...

Read More